AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30915647 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D sufficient children
Number of subjects: 387
Study 30915647 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D insufficient children
Number of subjects: 387
Study 30915647 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 387
Study 30915647 — intervention group
Group type: COMPARATOR
Intervention: Total infections
Number of subjects: 387
Study 30099417 — intervention group
Group type: EXPERIMENTAL
Intervention: Intubation tube of author's design with prophylactic tracheal sanation (vacuum aspiration and antiseptic irrigation every 3 hours), n = 50
Number of subjects: 90
Study 30099417 — intervention group
Group type: COMPARATOR
Intervention: Classical non-cuff intubation tube without prophylactic tracheal sanation, n = 40
Number of subjects: 90
Study 26975521 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention protocol implemented by care managers
Number of subjects: 76
Study 25458326 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone based text message reminders on healthy lifestyle principles
Number of subjects: 537
Study 21625252 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Number of subjects: 538
Study 21625252 — intervention group
Group type: COMPARATOR
Intervention: 5-Fluorouracil (5-FU)
Number of subjects: 538
Study 19170913 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 121
Study 19170913 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 121
Study 17984409 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release bupropion hydrochloride, 150 mg/d
Number of subjects: 312
Study 17984409 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release bupropion hydrochloride, 300 mg/d
Number of subjects: 312
Study 17984409 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 312
Study 16231970 — intervention group
Group type: EXPERIMENTAL
Intervention: Male circumcision (intervention group)
Number of subjects: 3274
Study 16231970 — intervention group
Group type: COMPARATOR
Intervention: Control group (circumcision offered at end of follow-up)
Number of subjects: 3274
Study 11998988 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (6 microg)
Number of subjects: 25
Study 11998988 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline (500 microg)
Number of subjects: 25
Study 11998988 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (12 microg)
Number of subjects: 25
Study 11998988 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (24 microg)
Number of subjects: 25
Study 10447247 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to reduce fat and non-milk extrinsic (NME) sugar
Number of subjects: 0
Study 10447247 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to reduce fat only, ad libitum sugar
Number of subjects: 0
Study 10447247 — intervention group
Group type: COMPARATOR
Intervention: Control group (no advice)
Number of subjects: 0
Study 7788825 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal meperidine (nasal group) - 27 mg per dose, self-administered, up to six puffs, with a minimum delay of 10 minutes between doses.
Number of subjects: 44
Study 7788825 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous meperidine injections (sc group) - 25 or 50 mg on request.
Number of subjects: 44
Study 7788825 — intervention group
Group type: COMPARATOR
Intervention: Both groups rated pain management as excellent or good.
Number of subjects: 44
Study 2082312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg
Number of subjects: 125
Study 2082312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 90 mg
Number of subjects: 125
Study 2082312 — intervention group
Group type: COMPARATOR
Intervention: Meperidine 50 mg
Number of subjects: 125
Study 2082312 — intervention group
Group type: COMPARATOR
Intervention: Meperidine 100 mg
Number of subjects: 125
Study 2082312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac 30 mg and 90 mg
Number of subjects: 125
Study 2082312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac and Meperidine
Number of subjects: 125
Study 160266 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilisation and manipulation
Number of subjects: 94
Study 160266 — intervention group
Group type: COMPARATOR
Intervention: Placebo physiotherapy
Number of subjects: 94
Study 30690747 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive restructuring (n=21)
Number of subjects: 43
Study 30690747 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive defusion (n=22)
Number of subjects: 43
Study 30508613 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Parenting Inventory (FPI)
Number of subjects: 248
Study 28070681 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon sacroplasty (BSP)
Number of subjects: 40
Study 28070681 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency sacroplasty (RFS)
Number of subjects: 40
Study 26330156 — intervention group
Group type: EXPERIMENTAL
Intervention: HFOV + VG
Number of subjects: 20
Study 26330156 — intervention group
Group type: COMPARATOR
Intervention: HFOV alone
Number of subjects: 20
Study 23646904 — intervention group
Group type: EXPERIMENTAL
Intervention: Eczema Education Programme (EEP)
Number of subjects: 257
Study 21540326 — intervention group
Group type: EXPERIMENTAL
Intervention: Small class sizes (13-17 students)
Number of subjects: 11601
Study 21540326 — intervention group
Group type: COMPARATOR
Intervention: Regular class sizes (22-25 students)
Number of subjects: 11601
Study 19178487 — intervention group
Group type: EXPERIMENTAL
Intervention: ingenol mebutate gel, 0.05%
Number of subjects: 58
Study 19178487 — intervention group
Group type: COMPARATOR
Intervention: vehicle gel
Number of subjects: 58
Study 17970230 — intervention group
Group type: EXPERIMENTAL
Intervention: Latex sensitization (specific IgE > 0.7 kU/I)
Number of subjects: 80
Study 17970230 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical reactions to latex (urticaria, conjunctivitis, angioedema, rhinitis, bronchial asthma)
Number of subjects: 80
Study 17970230 — intervention group
Group type: COMPARATOR
Intervention: Correlation with latex allergy
Number of subjects: 80
Study 15020025 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal recruitment and randomisation
Number of subjects: 14
Study 15020025 — intervention group
Group type: EXPERIMENTAL
Intervention: Consent and randomisation conducted on admission in labour
Number of subjects: 14
Study 15020025 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged recruitment and randomisation (two- or three-staged)
Number of subjects: 14
Study 15020025 — intervention group
Group type: EXPERIMENTAL
Intervention: Various study designs
Number of subjects: 14
Study 11749095 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention
Number of subjects: 510
Study 11749095 — intervention group
Group type: EXPERIMENTAL
Intervention: Outreach intervention
Number of subjects: 510
Study 11749095 — intervention group
Group type: EXPERIMENTAL
Intervention: In-reach intervention
Number of subjects: 510
Study 11749095 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 510
Study 9468077 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 0
Study 8124991 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.5 mg orally)
Number of subjects: 16
Study 8124991 — intervention group
Group type: EXPERIMENTAL
Intervention: Meperidine (1 mg/kg, subcutaneously)
Number of subjects: 16
Study 8124991 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal volunteers)
Number of subjects: 16
Study 8124991 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis patients
Number of subjects: 16
Study 2682898 — intervention group
Group type: EXPERIMENTAL
Intervention: De-Nol (tripotassium dicitrate bismuthate)
Number of subjects: 28
Study 2682898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 60570 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole (4 tablets daily for 6-14 days)
Number of subjects: 21
Study 60570 — intervention group
Group type: COMPARATOR
Intervention: Control (no antibacterial therapy)
Number of subjects: 21
Study 31642726 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training program (10-minute program, 3 times weekly for 12 weeks) targeting quadriceps, hip abductor, and core muscle groups
Number of subjects: 720
Study 31642726 — intervention group
Group type: COMPARATOR
Intervention: Observation group (no intervention)
Number of subjects: 720
Study 31642726 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training program
Number of subjects: 720
Study 31642726 — intervention group
Group type: COMPARATOR
Intervention: Observation group
Number of subjects: 720
Study 29945625 — intervention group
Group type: EXPERIMENTAL
Intervention: GSH+L-citrulline
Number of subjects: 75
Study 29945625 — intervention group
Group type: EXPERIMENTAL
Intervention: L-citrulline-malate
Number of subjects: 75
Study 29945625 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 75
Study 28820516 — intervention group
Group type: EXPERIMENTAL
Intervention: Reflexology intervention
Number of subjects: 180
Study 28820516 — intervention group
Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 180
Study 25616974 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM) group
Number of subjects: 173
Study 25616974 — intervention group
Group type: COMPARATOR
Intervention: Non-Diabetes Mellitus (non-DM) group
Number of subjects: 173
Study 25616974 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoglycemic DM patients (n = 24)
Number of subjects: 173
Study 25616974 — intervention group
Group type: COMPARATOR
Intervention: Non-Diabetes Mellitus (non-DM) patients
Number of subjects: 173
Study 24075613 — intervention group
Group type: EXPERIMENTAL
Intervention: PRGF-Endoret (3 injections on a weekly basis)
Number of subjects: 96
Study 24075613 — intervention group
Group type: COMPARATOR
Intervention: Durolane hyaluronic acid (1 single injection)
Number of subjects: 96
Study 21438778 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise withdrawal
Number of subjects: 26
Study 21438778 — intervention group
Group type: COMPARATOR
Intervention: Exercise maintenance
Number of subjects: 26
Study 18243430 — intervention group
Group type: EXPERIMENTAL
Intervention: Mw vaccine (1st dose of 1x10(9) heat killed organisms, 2nd dose of 5x10(8) organisms after 6 months)
Number of subjects: 28948
Study 18243430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28948
Study 18243430 — intervention group
Group type: EXPERIMENTAL
Intervention: Mw vaccine
Number of subjects: 28948
Study 18243430 — intervention group
Group type: EXPERIMENTAL
Intervention: Mw vaccine with BCG scars
Number of subjects: 28948
Study 18243430 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 28948
Study 17249432 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium hypochlorite (NaOCl)
Number of subjects: 23
Study 17249432 — intervention group
Group type: COMPARATOR
Intervention: Ferric sulfate (FeSO4)
Number of subjects: 23
Study 12714708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive functioning assessment in patients with CAO and TIA
Number of subjects: 39
Study 12714708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrovascular reserve capacity measured by transcranial Doppler ultrasound
Number of subjects: 39
Study 12714708 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic ratios measured by 1H‐MR spectroscopy
Number of subjects: 39
Study 12714708 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of lactate in noninfarcted regions
Number of subjects: 39
Study 12714708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive impairment correlation with CO2 reactivity and N-acetyl aspartate to creatine ratio
Number of subjects: 39
Study 11071432 — intervention group
Group type: EXPERIMENTAL
Intervention: Early signs of infarct on CT
Number of subjects: 260
Study 11071432 — intervention group
Group type: EXPERIMENTAL
Intervention: Early signs of infarct of more than 1/3 of the MCA territory
Number of subjects: 260
Study 8952816 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous linsidomine 10 mg
Number of subjects: 0
Study 8952816 — intervention group
Group type: COMPARATOR
Intervention: Parenteral isosorbide dinitrate
Number of subjects: 0
Study 1794814 — intervention group
Group type: EXPERIMENTAL
Intervention: Cut-off filter glasses
Number of subjects: 12
Study 1794814 — intervention group
Group type: COMPARATOR
Intervention: No cut-off filter glasses (control)
Number of subjects: 12
Study 6307516 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) at 3000 rad in ten fractions (PCI+)
Number of subjects: 172
Study 6307516 — intervention group
Group type: COMPARATOR
Intervention: Observation (PCI-)
Number of subjects: 172
Study 31473130 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral TXA regimen
Number of subjects: 53
Study 31473130 — intervention group
Group type: COMPARATOR
Intervention: Combined topical/IV/oral TXA
Number of subjects: 53
Study 29972742 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecovirimat 600 mg twice daily for 14 days
Number of subjects: 449
Study 29972742 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecovirimat 10 mg/kg for 14 days (monkeypox model)
Number of subjects: 449
Study 29972742 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecovirimat 40 mg/kg for 14 days (rabbitpox model)
Number of subjects: 449
Study 29972742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 449
Study 28388647 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Saccharomyces boulardii for 12 weeks
Number of subjects: 44
Study 28388647 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 44
Study 28388647 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Saccharomyces boulardii
Number of subjects: 44
Study 25609006 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus bevacizumab (cisplatin: 40 mg/m2, bevacizumab: 300 mg, every 2 weeks for 6 weeks)
Number of subjects: 58
Study 25609006 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin only (control group, n=27, cisplatin: 40 mg/m2 every 2 weeks for 6 weeks)
Number of subjects: 58
Study 24228532 — intervention group
Group type: EXPERIMENTAL
Intervention: Xiaozhi particles, integrated Taohong Siwu tang and Erchen tang
Number of subjects: 180
Study 24228532 — intervention group
Group type: COMPARATOR
Intervention: Xuezhikang capsule
Number of subjects: 180
Study 21906813 — intervention group
Group type: EXPERIMENTAL
Intervention: Ahmed‐FP7 valve implant
Number of subjects: 238
Study 21906813 — intervention group
Group type: COMPARATOR
Intervention: Baerveldt‐350 implant
Number of subjects: 238
Study 18926726 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive intervention group received three months of hormonal contraception and counseling by a community health nurse (CHN).
Number of subjects: 103
Study 18926726 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention group received counseling by a CHN and advised to schedule an appointment at a family planning clinic.
Number of subjects: 103
Study 17217210 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA 5% cream
Number of subjects: 60
Study 17217210 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzocaine 18% gel
Number of subjects: 60
Study 17217210 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine 5% ointment
Number of subjects: 60
Study 14624816 — intervention group
Group type: EXPERIMENTAL
Intervention: 7% carbon dioxide (CO2) gas inhalation
Number of subjects: 64
Study 14624816 — intervention group
Group type: EXPERIMENTAL
Intervention: High math anxiety individuals
Number of subjects: 64
Study 14624816 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 64
Study 10760191 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced practice nurse interventions during transitional care
Number of subjects: 0
Study 8633378 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate and alphacalcidol (group B)
Number of subjects: 48
Study 8633378 — intervention group
Group type: COMPARATOR
Intervention: Disodium etidronate and calcium carbonate (group A)
Number of subjects: 48
Study 7962386 — intervention group
Group type: EXPERIMENTAL
Intervention: Immuno-selected spermatozoa fraction
Number of subjects: 9
Study 7962386 — intervention group
Group type: COMPARATOR
Intervention: Control swim-up fraction
Number of subjects: 9
Study 7962386 — intervention group
Group type: EXPERIMENTAL
Intervention: Both immuno-depleted and swim-up sperm populations
Number of subjects: 9
Study 7962386 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall IVF performance
Number of subjects: 9
Study 3627711 — intervention group
Group type: EXPERIMENTAL
Intervention: Constantly monitored (CM) group with continuous transcutaneous oxygen monitoring (tcPO2)
Number of subjects: 296
Study 3627711 — intervention group
Group type: COMPARATOR
Intervention: Standard care (SC) group with intermittent monitoring of tcPO2
Number of subjects: 296
Study 3627711 — intervention group
Group type: EXPERIMENTAL
Intervention: CM group
Number of subjects: 296
Study 3627711 — intervention group
Group type: COMPARATOR
Intervention: SC group
Number of subjects: 296
Study 3627711 — intervention group
Group type: COMPARATOR
Intervention: Infants over 1000 g birthweight in SC group
Number of subjects: 296
Study 30746055 — intervention group
Group type: EXPERIMENTAL
Intervention: Sets of domain-specific exercises (SRT+CRT)
Number of subjects: 110
Study 30746055 — intervention group
Group type: COMPARATOR
Intervention: Sets of nondomain-specific exercises (SRT+PBO)
Number of subjects: 110
Study 27718284 — intervention group
Group type: EXPERIMENTAL
Intervention: C-NDL procedure
Number of subjects: 209
Study 27718284 — intervention group
Group type: EXPERIMENTAL
Intervention: endopelvic free anchorage procedure
Number of subjects: 209
Study 27718284 — intervention group
Group type: COMPARATOR
Intervention: TVT-O procedure
Number of subjects: 209
Study 25406953 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical insulin-like growth factor-1 (IGF-1) therapy
Number of subjects: 120
Study 25406953 — intervention group
Group type: COMPARATOR
Intervention: Intratympanic corticosteroid therapy (Dexamethasone)
Number of subjects: 120
Study 23962957 — intervention group
Group type: EXPERIMENTAL
Intervention: Form-only condition
Number of subjects: 0
Study 23962957 — intervention group
Group type: COMPARATOR
Intervention: Picture-associated condition
Number of subjects: 0
Study 22716204 — intervention group
Group type: EXPERIMENTAL
Intervention: metformin (3 g daily)
Number of subjects: 41
Study 22716204 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 41
Study 20116969 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-4/PEP-4
Number of subjects: 20
Study 20116969 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-6/PEP-4
Number of subjects: 20
Study 20116969 — intervention group
Group type: COMPARATOR
Intervention: VS
Number of subjects: 20
Study 18050189 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) alone
Number of subjects: 44
Study 18050189 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) plus intravenous methylprednisolone (IV MP)
Number of subjects: 44
Study 18050189 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) plus infliximab
Number of subjects: 44
Study 16085528 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency management (CM; payment for chewing at least 12 pieces/day on 10 of 15 intervention days, n = 34) plus standard treatment (ST) and brief feedback (BF)
Number of subjects: 97
Study 16085528 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief feedback (BF; n = 32) plus standard treatment (ST)
Number of subjects: 97
Study 16085528 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (ST; n = 31)
Number of subjects: 97
Study 12173710 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glutathione twice a day for 5 days
Number of subjects: 40
Study 12173710 — intervention group
Group type: COMPARATOR
Intervention: Saline solution twice a day for 5 days
Number of subjects: 40
Study 10226978 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline (300-500 mg orally at night for 4-22 weeks)
Number of subjects: 50
Study 10226978 — intervention group
Group type: COMPARATOR
Intervention: Control group (nCPAP therapy)
Number of subjects: 50
Study 8767921 — intervention group
Group type: EXPERIMENTAL
Intervention: IS-5-MN
Number of subjects: 0
Study 8767921 — intervention group
Group type: EXPERIMENTAL
Intervention: s.r. ISDN
Number of subjects: 0
Study 8767921 — intervention group
Group type: EXPERIMENTAL
Intervention: nitroglycerine-patches
Number of subjects: 0
Study 8767921 — intervention group
Group type: COMPARATOR
Intervention: Continuous application of organic nitrates
Number of subjects: 0
Study 8767921 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrate-free interval of 12 to 18 hours
Number of subjects: 0
Study 1457233 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure wrist band
Number of subjects: 6
Study 1457233 — intervention group
Group type: COMPARATOR
Intervention: Placebo wrist band
Number of subjects: 6
Study 1457233 — intervention group
Group type: COMPARATOR
Intervention: No wrist band condition
Number of subjects: 6
Study 6148877 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg nadolol
Number of subjects: 33
Study 6148877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg diazepam
Number of subjects: 33
Study 6148877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 31349876 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab (anti-IL-17A antibody) administered over 24 weeks
Number of subjects: 20
Study 29687524 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma Affect Regulation: Guide for Education and Therapy (TARGET)
Number of subjects: 31
Study 29687524 — intervention group
Group type: COMPARATOR
Intervention: Prolonged Exposure (PE)
Number of subjects: 31
Study 26211482 — intervention group
Group type: EXPERIMENTAL
Intervention: Subconjunctival glucose (50%)
Number of subjects: 5
Study 26211482 — intervention group
Group type: COMPARATOR
Intervention: Iso‐osmotic (8%) saline
Number of subjects: 5
Study 25231697 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton pump inhibitor (PPI) therapy for 6 months
Number of subjects: 71
Study 25231697 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional endoscopy
Number of subjects: 71